Filtered By:
Drug: Methylprednisolone
This page shows you your search results in order of relevance. This is page number 3.
Order by Relevance | Date
Total 251 results found since Jan 2013.
Can dose reduction be made in patients with allergic bronchopulmonary aspergillosis receiving high-dose omalizumab treatment?
Conclusions. Decreasing the total omalizumab dose does not cause clinical deterioration in ABPA after the disease is controlled.PMID:35850503 | DOI:10.23822/EurAnnACI.1764-1489.261
Source: European Annals of Allergy and Clinical Immunology - July 19, 2022 Category: Allergy & Immunology Authors: E T Korkmaz O Ayd ın D Mungan B A Sin Y S Demirel S Bavbek Source Type: research
Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions
CONCLUSIONS: Considering the potentially life-saving benefits of vaccination in a global pandemic environment, it is a safe and effective method to administer vaccines to at-risk patients using desensitization or split dosing techniques, based on their sensitivity status determined through a PEG skin test. This approach allows for the avoidance of preventing access to vaccines, while still ensuring the safety of patients.PMID:37345399 | DOI:10.5578/tt.20239920
Source: Tuberkuloz ve Toraks - June 22, 2023 Category: Respiratory Medicine Authors: Şeyma Özden Fatma Merve Tepetam Özge Atik Source Type: research
